Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Annexon Inc (NQ: ANNX )

3.870 -0.010 (-0.26%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,028,116
Open 3.950
Bid (Size) 3.740 (5)
Ask (Size) 4.060 (1)
Prev. Close 3.880
Today's Range 3.780 - 4.080
52wk Range 2.060 - 7.650
Shares Outstanding 47,722,995
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Annexon Reports Fourth Quarter and Year-End 2022 Financial Results and Reiterates Anticipated Milestones
From Annexon Biosciences
Via Globe NewsWire
Annexon Biosciences to Participate in the 43rd Annual Cowen Healthcare Conference
From Annexon Biosciences
Via Globe NewsWire

Performance

YTD
-19.21%
-19.21%
1 Month
-28.33%
-28.33%
3 Month
-23.06%
-23.06%
6 Month
-35.82%
-35.82%
1 Year
+28.15%
+28.15%

More News

Read More
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
From Annexon Biosciences
Via Globe NewsWire
Annexon Touts Final Huntington's Trial Data Confirming No New Safety Issues
Via Benzinga
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
From Annexon Biosciences
Via Globe NewsWire
Annexon Highlights Strategic Focus to Advance Four Flagship Complement Programs through Late-Stage Development and Progress Across Three Therapeutic Franchises
From Annexon Biosciences
Via Globe NewsWire
Annexon Appoints Industry Veteran, Dr. Rick Artis, as Chief Scientific Officer to Support the Advancement and Expansion of Complement-focused Portfolio
From Annexon Biosciences
Via Globe NewsWire
Annexon to Present at 41st Annual J.P. Morgan Healthcare Conference
From Annexon Biosciences
Via Globe NewsWire
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
From Annexon Biosciences
Via Globe NewsWire
Annexon: Q3 Earnings Insights
Via Benzinga
Annexon Reports Third Quarter 2022 Financial Results and Plans to Provide Updates on Complement Therapeutic Portfolio in January 2023
From Annexon Biosciences
Via Globe NewsWire
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
From Annexon Biosciences
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022
Via Benzinga
The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data Sooner
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Tesla, WD-40 Company And 40 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Tesla, Twitter And 76 Biggest Movers From Friday
Via Benzinga
The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug
Via Benzinga
79 Biggest Movers From Yesterday
Via Benzinga
10 Biggest Price Target Changes For Tuesday
Via Benzinga
103 Biggest Movers From Yesterday
Via Benzinga
53 Biggest Movers From Yesterday
Via Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
54 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.